IP Library › Granted Patent US 12,690,770
Granted Patent B2
US 12,690,770 · App. 17/911,809 · Granted Jul 28, 2026

System and method for T1 relaxation enhanced steady-state MRI

Inventors: Robert R. Edelman (Highland Park, IL); Ioannis Koktzoglou (Arlington Heights, IL)
Assignee: Endeavor Health Clinical Operations
A61B5/0044A61B5/055A61B5/742G01R33/385G01R33/50G01R33/5614A61B2576/023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,690,770
App. No.
17/911,809
Granted
Jul 28, 2026
Kind
B2
Abstract

A method for generating magnetic resonance (MR) images of a subject includes performing, using a magnetic resonance imaging (MRI) system, a steady-state pulse sequence to acquire MR data from a region of interest in the subject. The steady-state pulse sequence includes a contrast-modifying (CM) radio frequency (RF) pulse applied periodically at a predetermined time interval followed by a gradient spoiler pulse. The CM RF pulse has a flip angle with a value determined based on a minimum Ernst angle for a set of one or more background tissues in the region of interest that the CM RF pulse is configured to suppress with respect to a tissue of interest. The method further includes generating an image with Ti contrast based on the acquired MR data.

Claims (66)

1 . A method for generating magnetic resonance (MR) images of a subject, the method comprising:

performing, using a magnetic resonance imaging (MRI) system, a steady-state pulse sequence to acquire MR data from a region of interest in the subject, the steady-state pulse sequence comprising a contrast-modifying (CM) radio frequency (RF) pulse for T 1 -weighting applied periodically at a predetermined time interval throughout an acquisition of a plurality of echo signals using a plurality of imaging RF pulses, the CM RF pulse applied at each predetermined time interval prior to acquisition of at least two of the plurality of echo signals, and the CM RF pulse having a flip angle with a value determined based on a minimum Ernst angle for a set of one or more background tissues in the region of interest that the CM RF pulse is configured to suppress with respect to a tissue of interest; and

generating an image with T 1 contrast based on the acquired MR data.

2 . The method according to claim 1 , further comprising displaying the generated image on a display.

3 . The method according to claim 1 , wherein the set of one or more background tissues includes a fluid and the tissue of interest is blood.

4 . The method according to claim 1 , wherein the set of one or more background tissues includes an unenhanced myocardium and the tissue of interest is enhanced myocardium.

5 . The method according to claim 1 , wherein the set of one or more background tissues includes normal tissue and the tissue of interest is an abnormally enhancing tissue.

6 . The method according to claim 5 , wherein the abnormally enhancing tissue is one of a tumor or inflammation.

7 . The method according to claim 1 , wherein the flip angle of the CM RF pulse has a value greater than half the minimum Ernst angle for the set of one or more background tissues in the region of interest that the CM RF pulse is configured to suppress with respect to the tissue of interest and is determined using:

α

CM

>

0.5

×

cos

-

1

(

e

-

τ

/

T

1

⁢

min

)

where α CM is the flip angle in degrees of the CM RF pulse, cos −1 is the inverse cosine function yielding degrees, e is the mathematical constant approximately equal to 2.71828, t is the predetermined time interval, and T 1 min is the shortest longitudinal relaxation time in the set of one or more background tissues the CM RF pulse is configured to suppress.

8 . The method according to claim 1 , wherein the steady-state pulse sequence further comprises an α/2 store RF pulse applied prior to the CM RF pulse and an α/2 restore RF pulse applied following to the CM RF pulse.

9 . The method according to claim 1 , wherein the CM RF pulse is slice selective.

10 . The method according to claim 1 , wherein the predetermined time interval is greater than 50 ms.

11 . A magnetic resonance imaging (MRI) system comprising:

a magnet system configured to generate a polarizing magnetic field about at least a portion of a subject;

a plurality of gradient coils configured to apply at least one gradient field to the polarizing magnetic field;

a radio frequency (RF) system configured to apply an excitation field to the subject and to receive MR data from the subject; and

a computer system programmed to:

perform, using the MRI system, a steady-state pulse sequence to acquire MR data from a region of interest in the subject, the steady-state pulse sequence comprising a contrast-modifying (CM) radio frequency (RF) pulse for T 1 -weighting applied periodically at a predetermined time interval throughout an acquisition of a plurality of echo signals using a plurality of imaging RF pulses, the CM RF pulse applied at each predetermine time interval prior to acquisition of at least two of the plurality of echo signals, and the CM RF pulse having a flip angle with a value determined based on a minimum Ernst angle for a set of one or more background tissues in the region of interest that the CM RF pulse is configured to suppress with respect to a tissue of interest; and

generate an image with T 1 contrast based on the acquired MR data.

12 . The system according to claim 11 , further comprising a display and wherein the computer system is further programmed to display the generated image on the display.

13 . The system according to claim 11 , wherein the set of one or more background tissues includes a fluid and the tissue of interest is blood.

14 . The system according to claim 11 , wherein the set of one or more background tissues includes unenhanced myocardium and the tissue of interest is enhanced myocardium.

15 . The system according to claim 11 , wherein the set of one or more background tissues includes a normal tissue and the tissue of interest is abnormally enhancing tissue.

16 . The system according to claim 15 , the abnormally enhancing tissue is one of a tumor or inflammation.

17 . The system according to claim 11 , wherein the flip angle of the CM RF pulse has a value greater than half the minimum Ernst angle for the set of one or more background tissues in the region of interest that the CM RF pulse is configured to suppress with respect to the tissue of interest and is determined using:

α

CM

>

0.5

×

cos

-

1

(

e

-

τ

/

T

1

⁢

min

)

where α CM is the flip angle in degrees of the CM RF pulse, cos −1 is the inverse cosine function yielding degrees, e is the mathematical constant approximately equal to 2.71828, t is the predetermined time interval, and T 1 min is the shortest longitudinal relaxation time in the set of one or more background tissues the CM RF pulse is configured to suppress.

18 . The system according to claim 11 , wherein the pulse sequence further comprises an α/2 store RF pulse applied prior to the CM RF pulse and an α/2 restore RF pulse applied following to the CM RF pulse.

19 . The system according to claim 11 , wherein the CM RF pulse is slice selective.

20 . The system according to claim 11 , wherein the predetermined time interval is greater than 50 ms.

Assignments (2)
CHANGE OF NAME Recorded Apr 23, 2026
From: NORTHSHORE UNIVERSIKTY HEALTHSYSTEM
To: ENDEAVOR HEALTH CLINICAL OPERATIONS
Reel/Frame 075467/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2022
From: EDELMAN, ROBERT R.; KOKTZOGLOU, IOANNIS
To: NORTHSHORE UNIVERSITY HEALTHSYSTEM
Reel/Frame 061106/0897 →
Continuity (2)
Provisional Application 62991181 · Mar 18, 2020
Related Publication 20230139038A1 · May 4, 2023
References Cited (30)
US 7253620B1 · Derbyshire et al. · 2007 [cited by applicant]
US 7292039B1 · Laub et al. · 2007 [cited by applicant]
US 11857306B1 · Posse · 2024 [cited by examiner]
US 20030176782A1 · Graessner · 2003 [cited by applicant]
US 20080081986A1 · Slavin · 2008 [cited by examiner]
US 20140050379A1 · Miyazaki · 2014 [cited by applicant]
US 20140084918A1 · Kurokawa · 2014 [cited by applicant]
US 20150185301A1 · Hsu et al. · 2015 [cited by applicant]
US 20170176562A1 · Li et al. · 2017 [cited by applicant]
US 20190025396A1 · Edelman et al. · 2019 [cited by applicant]
WO WO2019083936 · 2019 [cited by applicant]
Johst, Sören, et al. “Time-of-flight magnetic resonance angiography at 7 T using venous saturation pulses with reduced flip angles.” Investigative radiology 47.8 (2012): 445-450. (Year: 2012). [cited by examiner]
Schmalbrok P, Hacker VA, Rao A. Three-dimensional steady-state MR angiography of the lower extremities. J Magn Reson Imaging 1994; 4(2):223-30. [cited by applicant]
Kellman P. et al. Cardiac First-Pass Perfusion MRI Using 3D trueFISP Parallel Imaging USing TSENSE. Proc. Intl. Soc. Mag. Reson. Med. 11 (2004). [cited by applicant]
Chung Y. et al. Inversion Recovery Prepared PSIF for FLAIR at 7T. Proc. Intl. Soc. Mag. Reson. Med. 21 (2013). [cited by applicant]
Scheffler K, Heid O, Hennig J. Magnetization preparation during the steady state: fat-saturated 3D TrueFISP. Magn. Reson. Med. 2001; 45(6):1075-1080. [cited by applicant]
Derbyshire J.A. et al. S5FP: Spectrally Selective Suppression with Steady-State Free Precession. Magn. Reson. Med. 54:918-928 (2005). [cited by applicant]
Koktzoglou I. et al. Radial Fast Interrupted Steady-State (FISS) Magnetic Resonance Imaging. Magn. Reson. Med. 79:2077-2087 (2018). [cited by applicant]
Reeder SB, Herzka DA, McVeigh ER. Signal-to-noise ratio behavior of steady-state free precession. Magn Reson Med. 2004; 52: 123-130. [cited by applicant]
Miller KL, Tijssen RHN, Stikov N, Okell TW. Steady-state MRI: methods for neuroimaging. Imaging Med. 2011; 3(1), 93-105. [cited by applicant]
Edelman RR, Sheehan JJ, Dunkle E, Schindler N, Carr J, Koktzoglou I. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical consideration and clinical feasibil… [cited by applicant]
Derbyshire J.A. et al. Reduction of Flow Artifacts in Balanced SSFP Imaging Using S5FP. Proc. Intl. Soc. Mag. Reson. Med. 16 (2008). [cited by applicant]
Koktzoglou I. et al. Radial Fast Interrupted Steady-State (FISS) Cine Imaging for the Evaluation of Heart Valves and Coronary Arteries. CMR 2018—A joint Euro(MR) SCMR Meeting Abstract Supplement. p. 196-197. [cited by applicant]
Edelman R.R. et al. Quantitative Coronary Flow Imaging Using Breath-hold Cine FISS Arterial Spin-Labeled MR Angiography. CMR—2018 A joint Euro(MR) SCMR Meeting Abstract Supplement. p. 391. [cited by applicant]
Edelman R.R. et al. Dynamic Flow Imaging and Quantification Using Cine FISS Arterial Spin Labeling. Proc. Intl. Soc. Mag. Reson. Med. 26(2018). [cited by applicant]
Edelman R.R. et al. Cardiovascular Cine Imaging and Flow Evaluation Using Fast Interrupted Steady-State (FISS) Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance (2018) 20:12. [cited by applicant]
Marckmann P. et al. Nephrogenic Systemic Fibrosis Suspected Causative Role of Gadodiamide used for Contrast-Enhanced Magnetic Resonance Imaging, J. Am. Soc. Nephrol. 2006, 17(9) 2359-2362. [cited by applicant]
PCT/US2021/021895—International Search Report and Written Opinion—May 26, 2021, 11 pages. [cited by applicant]
Edelman, R., et al. “Twofold improved tumor-to-brain contrast using a novel T1 relaxation-enhanced steady-state (T1RESS) MRI technique.” Science Advances 6.44 (Oct. 2020): eabd1635. [cited by applicant]
Extended European Search Report, corresponding to EP 21771095.3, dated Mar. 12, 2024. [cited by applicant]